Pyridazine compounds as glycogen synthase kinase 3 inhibitors

US7994160B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Sean Colm Turner · Ludwigshafen, DE
• Margaretha Henrica Maria Bakker · Ludwigshafen, DE
• Roland Grandel · Dossenheim, DE
• Michael Vierling · Ludwigshafen, DE

Key dates

• Filing date: Jul 12, 2006
• Grant date: Aug 9, 2011
• Expiry date: Feb 19, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are pyridazine compounds of the formula I which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds:In formula I indicates a single bond or a double bond;